Kurin’s Blood Culture Contaminant Diverter Gets CE Mark
May 21, 2019
Kurin has earned the CE Mark for its Kurin Lock, allowing the devicemaker’s FDA-cleared blood culture collection sets to be marketed in the European Economic Area with the novel contaminant diverter.
The Kurin Lock specimen diversion device works with Kurin’s blood culture set to automatically divert the initial portion of blood in each draw, which can contain potential contaminants.
Patients may be exposed to unnecessary antibiotics as a result of contaminated blood cultures, the company said, which can also lead to extended hospital stays.